Rapid Pathogen Screening (RPS) is a bio-technology company in Sarasota. The company is developing test kits, which will be able to spot the flu and sexually transmitted diseases without waiting for lab work. They are also working on a kit that will test for exposure to nerve agents, including Sarin and VX. RPS was founded in 2004 and opened its state-of-the-art research laboratory in Sarasota in 2006. The company's first product was the RPS Adeno Detector, which can test for viral conjunctivitis, otherwise known as "pink eye" in the physician's office. RPS soon realized that the same technology used to detect viral conjunctivitis could also detect other diseases.